5941153bb7
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
87 lines
4.6 KiB
Markdown
87 lines
4.6 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Toxicology screening for xylazine."
|
||
description: "Provides that, if the coroner reasonably suspects the cause of the person's death to be accidental or intentional overdose of an opioid or if the person was administered an overdose intervention drug prior to death and was unresponsive to the overdose intervention drug, the coroner shall test certain bodily fluids to determine whether the bodily fluid contained any amount, including a trace amount, of xylazine at the time of the person's death."
|
||
jurisdiction: "us/states/in"
|
||
legislature: "Indiana General Assembly"
|
||
session: "2023"
|
||
identifier: "HB 1286"
|
||
citation: "Indiana HB 1286 (2023)"
|
||
classification: ["bill"]
|
||
subjects: ["CORONERS", "DEATH", "DRUGS AND MEDICINES"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Jean Leising", "Jennifer Meltzer", "Tyler Johnson"]
|
||
version_count: 4
|
||
action_count: 21
|
||
vote_count: 1
|
||
first_action: "2023-01-11"
|
||
last_action: "2023-04-20"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/e352ea8e-124e-419a-8d33-df8d5d415546"
|
||
source_url: "http://iga.in.gov/legislative/2023/bills/house/1286"
|
||
source_hash: "7c8800162c9a21b02b46ed239b37989f5087c4d366854fe6aad83f1b715276d1"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-in"]
|
||
---
|
||
|
||
# Indiana HB 1286 (2023) — Toxicology screening for xylazine.
|
||
|
||
Provides that, if the coroner reasonably suspects the cause of the person's death to be accidental or intentional overdose of an opioid or if the person was administered an overdose intervention drug prior to death and was unresponsive to the overdose intervention drug, the coroner shall test certain bodily fluids to determine whether the bodily fluid contained any amount, including a trace amount, of xylazine at the time of the person's death.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Enrolled House Bill (H)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/HB1286/versions/HB1286.04.ENRS)
|
||
2. **House Bill (H)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/HB1286/versions/HB1286.02.COMH)
|
||
3. **House Bill (S)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/HB1286/versions/HB1286.03.COMS)
|
||
4. **Introduced House Bill (H)** (committee substitute) — [source](http://in-proxy.openstates.org/2023/bills/HB1286/versions/HB1286.01.INTR)
|
||
|
||
## Votes
|
||
|
||
- HB 1286 - Johnson - 3rd Reading — **49–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Jean Leising — primary (person)
|
||
- Jennifer Meltzer — primary (person)
|
||
- Tyler Johnson — primary (person)
|
||
- Ann Vermilion — coauthor (person)
|
||
- Greg Taylor — cosponsor (person)
|
||
- Ryan Lauer — coauthor (person)
|
||
- Victoria Garcia Wilburn — coauthor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2023-01-11** Coauthored by Representative Lauer
|
||
- **2023-01-11** Authored by Representative Meltzer
|
||
- **2023-01-11** First reading: referred to Committee on Local Government `reading-1, referral-committee`
|
||
- **2023-01-19** Representative Vermilion A added as coauthor
|
||
- **2023-01-31** Representative Garcia Wilburn V added as coauthor
|
||
- **2023-02-14** Committee report: do pass, adopted `committee-passage`
|
||
- **2023-02-16** Second reading: ordered engrossed `reading-2`
|
||
- **2023-02-20** Senate sponsors: Senators Johnson and Leising
|
||
- **2023-02-20** Third reading: passed; Roll Call 154: yeas 96, nays 0 `passage, reading-3, reading-3`
|
||
- **2023-02-21** Referred to the Senate `referral`
|
||
- **2023-02-28** First reading: referred to Committee on Local Government `reading-1, referral-committee`
|
||
- **2023-03-20** Committee report: do pass, adopted `committee-passage`
|
||
- **2023-03-20** Senator Taylor G added as cosponsor
|
||
- **2023-03-23** Second reading: ordered engrossed `reading-2`
|
||
- **2023-03-27** Third reading: passed; Roll Call 253: yeas 49, nays 0 `passage, reading-3, reading-3`
|
||
- **2023-03-28** Returned to the House without amendments `receipt`
|
||
- **2023-04-03** Signed by the Speaker `passage`
|
||
- **2023-04-04** Signed by the President Pro Tempore `passage`
|
||
- **2023-04-17** Signed by the President of the Senate `passage`
|
||
- **2023-04-20** Signed by the Governor `executive-signature`
|
||
- **2023-04-20** Public Law 71 `became-law`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/e352ea8e-124e-419a-8d33-df8d5d415546`. Confidence: reported (aggregated from official Indiana legislature records).
|
||
|